Logo Logo Logo Logo Logo
  • Home
  • Science
    • Scientific Advisory Board
    • Competitive Advantage
    • Patent Groups
    • Biopharma Pipeline
    • Research Partners
  • Team
  • Investors
    • Press Releases
    • SEC Filings
  • Contact
    • Sign up for News
  • Home
  • Science
    • Scientific Advisory Board
    • Competitive Advantage
    • Patent Groups
    • Biopharma Pipeline
    • Research Partners
  • Team
  • Investors
    • Press Releases
    • SEC Filings
  • Contact
    • Sign up for News

Archive

22 January, 2019 in
Gary Henrie – Corporate Counsel
27 August, 2018 in
Monica Poss – VP of Corporate Planning
01 August, 2017 in
David Rabinowitz — Quality Manager
01 June, 2017 in
Dr. Ulrich Reimann-Philipp — Chief Botanist
01 May, 2017 in
Tom Arcuragi — Senior VP of Marketing
01 April, 2017 in
Zach Swarts — Chief Financial Officer
01 March, 2017 in
Kevin Kuethe — Chief Operating Officer
02 February, 2017 in
Dr. Andrea Small-Howard — Chief Science Officer
01 January, 2017 in
John Poss — Chairman and CEO

GBSciences, Inc.

Next generation cannabinoid research and development.